Corona Remedies IPO Subscription Status
Corona Remedies IPO was subscribed 137.04 times when bidding closed on 10 Dec 2025: QIB 278.52x, NII 208.88x, Retail 28.73x.
The Corona Remedies IPO has been subscribed 137.04x times overall. Retail investors have shown interest with bids for 28.73x the shares available. The Non-Institutional Investor (NII) category has been subscribed 208.88x. Within NII, Big HNI (B-HNI) subscribed 234.02x and Small HNI (S-HNI) subscribed 158.62x. Qualified Institutional Buyers (QIBs) have subscribed 278.52x. Data last updated on 03 Sep, 02:08 PM.
The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 08 Dec, 2025 and closes on 10 Dec, 2025. The shares are expected to list on stock exchanges on 15 Dec, 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| QIB | - of 12,88,732 38,119.37 Cr | 278.52x |
| NII | - of 9,66,549 21,441.47 Cr | 208.88x |
| Retail | - of 22,55,281 6,881.98 Cr | 28.73x |
| Employee | - of 61,320 95.89 Cr | 14.72x |
| TOTAL | - 40,13,266 applications 66,538.70 Cr | 137.04x |
Corona Remedies IPO Basis of Allotment
Final Final figures published by the registrar, after technical rejections. Allotment price ₹1,061.
| Category | AppsApplications | GotAllottees | Odds |
|---|---|---|---|
| TOTAL 101.01x subscribed | 40,13,266 | 1,59,573 | 1 in 251 in 25 |
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
High demand detected. The retail category is heavily oversubscribed, making the allotment a lottery where only 1 out of every 29 applicants will be successful.
Market Sentiment
Strong grey market premium of 484% suggests exceptional listing gains and high bullish sentiment among traders.
Institutional Backing
Massive institutional interest with QIBs subscribing 278.52x. This often signals long-term confidence from professional funds.
Day-wise subscription history
End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
10 Dec 2025
Day 3 |
144.54x | ▼ | |
|
QIB293.80x
BHNI-
SHNI-
Retail30.39x
|
|||
|
09 Dec 2025
Day 2 |
9.96x | ▼ | |
|
QIB1.76x
BHNI-
SHNI-
Retail6.90x
|
|||
|
08 Dec 2025
Day 1 |
0.67x | ▼ | |
|
QIB0.00x
BHNI-
SHNI-
Retail0.96x
|
|||
Corona Remedies IPO dates
From the bidding window to listing. Today is 11 October.
- Open 08 Dec 2025
- Close 10 Dec 2025
- Allotment 11 Dec 2025
- Refund/credit 12 Dec 2025
- Listing 15 Dec 2025
Corona Remedies IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds marked with applicant counts are computed from the exchange's actual application data (applicants ÷ allotment slots); others assume minimum-size bids at the current subscription multiple. Retail and HNI allotment is by SEBI-mandated lottery of the minimum application when oversubscribed; QIB allotment is proportionate. Numbers move until subscription closes. This is not investment advice.
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during market hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Corona Remedies IPO?
As of IPO close date (10 Dec, 2025), the Corona Remedies IPO is subscribed 137.04x times. Retail category is 28.73x, and NII is 208.88x subscribed.
When is the allotment date for Corona Remedies IPO?
The allotment for Corona Remedies IPO is expected to be finalized on 11 December, 2025.
What is the GMP of Corona Remedies?
The Grey Market Premium (GMP) for Corona Remedies is currently ₹300, indicating a potential listing gain of 484%.
When will Corona Remedies IPO list on the stock market?
Corona Remedies is scheduled to list on BSE and NSE on 15 December, 2025.
What are the chances of getting allotment in Corona Remedies IPO?
The retail category is oversubscribed at 28.73x, meaning allotment is by lottery. Statistically, approximately 1 in 29 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
What does QIB subscription of 278.52x mean for Corona Remedies IPO?
Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 278.52x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.
How to check Corona Remedies IPO allotment status?
After the allotment date (11 Dec, 2025), you can check your Corona Remedies IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.
Explore Corona Remedies IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
